MediciNova, Inc. (MNOV)
1.42
-0.03
(-2.07%)
USD |
NASDAQ |
Oct 16, 16:00
1.43
+0.01
(+0.70%)
After-Hours: 20:00
MediciNova Research and Development Expense (Annual) : 7.135M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 7.135M |
| December 31, 2024 | 7.174M |
| December 31, 2023 | 5.638M |
| December 31, 2022 | 8.931M |
| December 31, 2021 | 8.512M |
| December 31, 2020 | 7.464M |
| December 31, 2019 | 6.055M |
| December 31, 2018 | 5.626M |
| December 31, 2017 | 4.224M |
| December 31, 2016 | 3.519M |
| December 31, 2015 | 3.017M |
| December 31, 2014 | 3.260M |
| Date | Value |
|---|---|
| December 31, 2013 | 3.329M |
| December 31, 2012 | 5.013M |
| December 31, 2011 | 7.785M |
| December 31, 2010 | 9.711M |
| December 31, 2009 | 10.87M |
| December 31, 2008 | 13.83M |
| December 31, 2007 | 42.12M |
| December 31, 2006 | 32.17M |
| December 31, 2005 | 22.46M |
| December 31, 2004 | 11.21M |
| December 31, 2003 | 4.723M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 93.26M |
| Viking Therapeutics, Inc. | 344.96M |
| IDEAYA Biosciences, Inc. | 314.70M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |
| Alnylam Pharmaceuticals, Inc. | 1.320B |